Dexcom has issued a Class I recall for its G6 Android app due to crashes that could cause users to miss critical glucose ...
Dexcom is facing scrutiny and class-action lawsuits over alleged safety and accuracy issues with its G7 monitor.
After dealing with a deployment problem with glucose monitors earlier this year, interim CEO Jake Leach said improving ...
However, the company's financial results have been pretty strong. And if DexCom can keep that up in its next quarterly update ...
Stifel projected that the 15-day sensor could enhance DexCom’s gross margin in 2026, potentially contributing to year-over-year EBITDA margin expansion. The firm acknowledged certain risks, including ...
DexCom, Inc. is a medical device company, which engages in the design, development, and commercialization of glucose monitoring systems for ambulatory use by people with diabetes. Its products include ...
Kirby McInerney LLP reminds investors who purchased DexCom, Inc. (“DexCom” or the “Company”) (NASDAQ:DXCM) securities to contact Thomas W. Elrod of Kirby ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback